Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug
pharmaphorum
JULY 15, 2022
The substance patent expired in 2007. ” “Given the importance of this issue to patients, payors (including the federal government), and prescription-drug competition, this court should grant review,” it adds.
Let's personalize your content